The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

Healthcare’s relationships with AI and digital transformation are a mix of excitement and uncertainty. Even as hospitals begin to see returns on their technology deployments, leaders acknowledge that ...

The Rural Health Transformation Program (RHTP) is more than a funding bill: It’s a $50 billion lifeline for rural hospitals on the brink of collapse, and time is running out to be positioned for ...

Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group's Optum subsidiary is hoping to change the dynamic through what they claim is a real-time ...

As the mental health crisis in the U.S. grows, mental health professionals are increasingly struggling due to workforce shortages. More than half of therapists report having feelings of burnout. And ...

GSK finally has the long-awaited FDA approval it sought for blood cancer drug Blenrep. Three years after the pharmaceutical giant pulled the multiple myeloma therapy from the market, the FDA approved ...

If you had told me five years ago that concierge medicine would go mainstream, I probably would’ve laughed. The perception was pretty fixed: it was a perk for senior leadership, a flashy benefit for ...

Frank Vinluan is senior biopharma reporter for MedCity News. He previously held business reporting positions at Xconomy, The Seattle Times, The Des Moines Register, and the Triangle Business Journal.

As always, this year's HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s ...